2-nitro-alpha-desmotroposantonin
ID: ALA4098029
PubChem CID: 137661585
Max Phase: Preclinical
Molecular Formula: C15H17NO5
Molecular Weight: 291.30
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
ID: ALA4098029
PubChem CID: 137661585
Max Phase: Preclinical
Molecular Formula: C15H17NO5
Molecular Weight: 291.30
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1c(O)c([N+](=O)[O-])c(C)c2c1[C@@H]1OC(=O)[C@@H](C)[C@@H]1CC2
Standard InChI: InChI=1S/C15H17NO5/c1-6-9-4-5-10-7(2)15(18)21-14(10)11(9)8(3)13(17)12(6)16(19)20/h7,10,14,17H,4-5H2,1-3H3/t7-,10-,14+/m0/s1
Standard InChI Key: QFCUJYMUVGFDOK-MRCLBUSBSA-N
Molfile:
RDKit 2D 23 25 0 0 0 0 0 0 0 0999 V2000 17.3363 -9.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.6186 -9.3720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.9052 -9.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.9052 -10.6133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.1938 -11.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.4760 -10.6133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.4760 -9.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.1938 -9.3770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7584 -11.0268 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 16.6269 -11.0246 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.3363 -10.6133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.9432 -11.1631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 17.6130 -11.9098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 16.7975 -11.8283 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 18.0303 -12.6253 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 18.7542 -10.9857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 18.0491 -10.2029 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 16.0432 -11.6124 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 15.1954 -8.5540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 13.7640 -9.3757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.7653 -8.5527 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 13.0505 -9.7860 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.1954 -11.8541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 3 2 1 0 4 3 1 0 4 5 2 0 6 5 1 0 7 6 2 0 8 7 1 0 3 8 2 0 6 9 1 0 4 10 1 0 11 10 1 0 11 1 1 0 11 12 1 0 13 12 1 0 14 13 1 0 10 14 1 0 13 15 2 0 12 16 1 6 11 17 1 6 10 18 1 6 8 19 1 0 7 20 1 0 20 21 1 0 20 22 2 0 5 23 1 0 M CHG 2 20 1 21 -1 M END
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 291.30 | Molecular Weight (Monoisotopic): 291.1107 | AlogP: 2.71 | #Rotatable Bonds: 1 |
Polar Surface Area: 89.67 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.55 | CX Basic pKa: ┄ | CX LogP: 3.55 | CX LogD: 3.32 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.49 | Np Likeness Score: 1.20 |
1. Chinthakindi PK, Singh J, Gupta S, Nargotra A, Mahajan P, Kaul A, Ahmed Z, Koul S, Sangwan PL.. (2017) Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships., 127 [PMID:27847171] [10.1016/j.ejmech.2016.11.018] |
Source(1):